| Serial Number | 90133236 |
| Word Mark | FIBROBODIES |
| Filing Date | Monday, August 24, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, March 22, 2022 |
| Registration Number | 6674974 |
| Registration Date | Tuesday, March 22, 2022 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 24, 2021 |
| Goods and Services | Pharmaceutical preparations for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and peroral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; pharmaceutical drugs for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and peroral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; Biochemical medicines for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; chemical preparations for pharmaceutical purposes, namely, for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; diagnostic agents for medical purposes; pharmaceutical substances and preparations for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; carrier excipients consisting of compounds that facilitate delivery of pharmaceutical preparations |
| Pseudo Mark | FIBRO BODIES |
| Goods and Services | Chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals for treating fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease |
| Goods and Services | Medical services, namely, in vitro analysis for medical and pharmaceutical use; Medical services, namely, in vitro testing for medical and pharmaceutical use; consultancy and information services provided via the Internet relating to pharmaceutical products |
| Goods and Services | Pharmaceutical research services; conducting clinical trials for others relating to pharmaceuticals; pharmaceutical research and development; pharmaceutical product evaluation; consultancy relating to pharmaceutical research and development; laboratory research services relating to pharmaceuticals; providing information about the results of clinical trials for pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; scientific research services in the field of proteins, antibodies, microorganisms and cells; research and development services in the field of antibody technology; design and development of medical technology |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, September 26, 2020 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, September 26, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, September 26, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, September 26, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | LinXis B.V. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | AMSTERDAM 1081GN NL |
| Party Name | LinXis B.V. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | AMSTERDAM 1081GM NL |
| Party Name | LinXis B.V. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | AMSTERDAM 1081GM NL |
| Event Date | Event Description |
| Thursday, August 27, 2020 | NEW APPLICATION ENTERED |
| Saturday, September 26, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, December 19, 2020 | ASSIGNED TO EXAMINER |
| Sunday, December 27, 2020 | NON-FINAL ACTION WRITTEN |
| Sunday, December 27, 2020 | NON-FINAL ACTION E-MAILED |
| Sunday, December 27, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, March 4, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, June 2, 2021 | ASSIGNED TO LIE |
| Friday, June 4, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, June 4, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, July 20, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 4, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 24, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 18, 2022 | TEAS DELETE 1(B) BASIS RECEIVED |
| Tuesday, August 24, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 19, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 18, 2022 | NOTICE OF ALLOWANCE CANCELLED |
| Friday, February 11, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Friday, February 11, 2022 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| Tuesday, March 22, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, August 22, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, August 22, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, August 22, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, August 22, 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Wednesday, February 19, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, February 19, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, February 19, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, February 19, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, February 19, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, August 22, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, August 22, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |